Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Related content
Volume 9, Number 6, June 2011

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Free Content Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation
pp. 1097-1107(11)
Authors: COX, D.; KERRIGAN, S. W.; WATSON, S. P.

Favourites:Add to Favourites

Free Content Economic impact of an electronic alert system to prevent venous thromboembolism in hospitalised patients
pp. 1108-1115(8)
Authors: LECUMBERRI, R.; PANIZO, E.; GOMEZ-GUIU, A.; VAREA, S.; GARCÍA-QUETGLAS, E.; SERRANO, M.; GARCÍA-MOURIZ, A.; MARQUÉS, M.; GÓMEZ-OUTES, A.; PÁRAMO, J. A.

Favourites:Add to Favourites

Free Content RVO – Real value obscure
pp. 1116-1118(3)
Author: WATSON, H. G.

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study
pp. 1126-1132(7)
Authors: LE GAL, G.; CARRIER, M.; KOVACS, M. J.; BETANCOURT, M. T.; KAHN, S. R.; WELLS, P. S.; ANDERSON, D. A.; CHAGNON, I.; SOLYMOSS, S.; CROWTHER, M.; RIGHINI, M.; DELLUC, A.; WHITE, R. H.; VICKARS, L.; RODGER, M.

Favourites:Add to Favourites

Free Content Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism
pp. 1133-1142(10)
Authors: HEIT, J. A.; CUNNINGHAM, J. M.; PETTERSON, T. M.; ARMASU, S. M.; RIDER, D. N.; DE ANDRADE, M.

Favourites:Add to Favourites

Free Content Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation
pp. 1143-1148(6)
Authors: TOSETTO, A.; CASTAMAN, G.; PLUG, I.; RODEGHIERO, F.; EIKENBOOM, J.

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content Incidence and predictors of indwelling arterial catheter-related thrombosis in children
pp. 1157-1162(6)
Authors: BROTSCHI, B.; HUG, M. I.; LATAL, B.; NEUHAUS, D.; BUERKI, C.; KROISS, S.; SPOERRI, C.; ALBISETTI, M.

Favourites:Add to Favourites

Free Content Successful immune tolerance induction by FVIII in hemophilia A patients with inhibitor may occur without deletion of FVIII-specific T cells
pp. 1163-1170(8)
Authors: PAUTARD, B.; D’OIRON, R.; LI THIAO TE, V.; LAVEND’HOMME, R.; SAINT-REMY, J.-M.; PEERLINCK, K.; JACQUEMIN, M.

Favourites:Add to Favourites

Free Content Thrombomodulin analogues for the treatment of ischemic stroke
pp. 1171-1173(3)
Authors: ANDREOU, A. P.; CRAWLEY, J. T. B.

Favourites:Add to Favourites

Free Content The thrombomodulin analog Solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model
pp. 1174-1182(9)
Authors: SU, E. J.; GEYER, M.; WAHL, M.; MANN, K.; GINSBURG, D.; BROHMANN, H.; PETERSEN, K. U.; LAWRENCE, D. A.

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa)
pp. 1191-1199(9)
Authors: TIEDE, A.; FRIEDRICH, U.; STENMO, C.; ALLEN, G.; GIANGRANDE, P.; GOUDEMAND, J.; HAY, C.; HOLMSTRÖM, M.; KLAMROTH, R.; LETHAGEN, S.; MCKENZIE, S.; MIESBACH, W.; NEGRIER, C.; YUSTE, V. J.; BERNTORP, E.

Favourites:Add to Favourites

Free Content Life-threatening hemorrhage and prolonged wound healing are remarkable phenotypes manifested by complete plasminogen activator inhibitor-1 deficiency in humans
pp. 1200-1206(7)
Authors: IWAKI, T.; TANAKA, A.; MIYAWAKI, Y.; SUZUKI, A.; KOBAYASHI, T.; TAKAMATSU, J.; MATSUSHITA, T.; UMEMURA, K.; URANO, T.; KOJIMA, T.; TERAO, T.; KANAYAMA, N.

Favourites:Add to Favourites

Free Content Vicinal thiols are required for activation of the αIIbβ3 platelet integrin
pp. 1207-1215(9)
Authors: MANICKAM, N.; AHMAD, S. S.; ESSEX, D. W.

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content Circulating matrix γ-carboxyglutamate protein (MGP) species are refractory to vitamin K treatment in a new case of Keutel syndrome
pp. 1225-1235(11)
Authors: CRANENBURG, E. C. M.; VAN SPAENDONCK-ZWARTS, K. Y.; BONAFE, L.; MITTAZ CRETTOL, L.; RÖDIGER, L. A.; DIKKERS, F. G.; VAN ESSEN, A. J.; SUPERTI-FURGA, A.; ALEXANDRAKIS, E.; VERMEER, C.; SCHURGERS, L. J.; LAVERMAN, G. D.

Favourites:Add to Favourites

Free Content Translational evidence of endothelial damage in obese individuals: inflammatory and prothrombotic responses
pp. 1236-1245(10)
Authors: HANZU, F. A.; PALOMO, M.; KALKO, S. G.; PARRIZAS, M.; GARAULET, M.; ESCOLAR, G.; GOMIS, R.; DIAZ-RICART, M.

Favourites:Add to Favourites

Free Content Long-term stability of the Scientific and Standardization Committee Secondary Coagulation Standard (SSC Lot no. 3)
pp. 1246-1248(3)
Authors: HUBBARD, A. R.; KITCHEN, S.; BEEHARRY, M.; BEVAN, S. A.; BOWYER, A.

Favourites:Add to Favourites

Free Content Genetic variants of F11, statin use and venous thrombosis
pp. 1249-1251(3)
Authors: BARE, L. A.; ARELLANO, A. R.; TONG, C. H.; BEZEMER, I.; LIJFERING, W. M.; DEVLIN, J. J.; REITSMA, P. H.; ROSENDAAL, F. R.

Favourites:Add to Favourites

Free Content ISTH overt disseminated intravascular coagulation score in patients with septic shock: automated immunoturbidimetric soluble fibrin assay vs. D-dimer assay
pp. 1252-1255(4)
Authors: GRIS, J.-C.; FAILLIE, J.-L.; COCHERY-NOUVELLON, É.; LISSALDE-LAVIGNE, G.; LEFRANT, J.-Y.

Favourites:Add to Favourites

Free Content Factor X and factor VII binding to endothelial protein C receptor differs between species
pp. 1255-1257(3)
Authors: PUY, C.; HERMIDA, J.; MONTES, R.

Favourites:Add to Favourites

Free Content Association of the angiotensin type 1 receptor gene A1166C polymorphisms with myocardial infarction: a meta-analysis
pp. 1258-1260(3)
Authors: ZHANG, H.; SUN, M.L.; PENG, J.; SUN, T.; ZHANG, Y.; YANG, J.M.

Favourites:Add to Favourites

Free Content Recurrent venous thrombosis, post-thrombotic syndrome and quality of life after catheter-directed thrombolysis in severe proximal deep vein thrombosis
pp. 1261-1263(3)
Authors: GHANIMA, W.; KLEVEN, I. W.; ENDEN, T.; ROSALES, A.; WIK, H. S.; PEDERSTAD, L.; HOLME, P. A.; SANDSET, P. M.

Favourites:Add to Favourites

Free Content Successful long-term replacement therapy with FXIII concentrate (Fibrogammin® P) for severe congenital factor XIII deficiency: a prospective multicentre study
pp. 1264-1266(3)
Authors: DREYFUS, M.; BARROIS, D.; BORG, J.-Y.; CLAEYSSENS, S.; TORCHET, M.-F.; ARNUTI, B.; PAUTARD, B.

Favourites:Add to Favourites
Favourites:Add to Favourites

Free Content Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin: reply to a rebuttal
pp. 1268-1269(2)
Authors: LEE, K. N.; JACKSON, K. W.; CHRISTIANSEN, V. J.; MCKEE, P. A.

Favourites:Add to Favourites

Free Content Prophylaxis with low-dose low molecular weight heparin during pregnancy and the puerperium: is it effective? A rebuttal
pp. 1269-1271(3)
Authors: PATEL, J. P.; PATEL, R. K.; DAVIES, J. G.; ARYA, R.

Favourites:Add to Favourites

Free Content Prophylaxis with low-dose low molecular weight heparin during pregnancy and the puerperium: is it effective? Reply to a rebuttal
pp. 1272-1273(2)
Authors: ROETERS VAN LENNEP, J. E.; MEIJER, E.; KLUMPER, F. J. C. M.; MIDDELDORP, J. M.; BLOEMENKAMP, K. W. M.; MIDDELDORP, S.

Favourites:Add to Favourites

Free Content Join ISTH
pp. 1274-1274(1)

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more